Form 4 for BIIB Biogen
Accepted 2022-01-21 00:00:00 ET · period of report 2022-01-19 · accession 0001127602-22-001862 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-01-21 | 2022-01-19 | BIIB | Guindo Chirfi | Head of Glob Prod Strat, Com | A - Grant | $0.00 | +3,088 | 6,007 | +106% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-01-19 | A | A | 3,088 | $0.00 | 6,007 | D | — | — | (F1) Represents shares earned upon satisfaction of certain performance conditions associated with performance stock units granted on February 12, 2019. The shares will vest on February 12, 2022. |